CIK 0000874716
- Large accelerated filer
IDEXX LABORATORIES INC /DE
Sign in to watch- Ticker
- IDXX
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 010393723
- Phone
- +1 207-556-0300
- Business address
- ONE IDEXX DRIVE, WESTBROOK, ME, 04092-2041
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $28,567,935
- in 5 filings
Net −$28,567,935. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- MAZELSKY JONATHAN JAY −$17.7M Executive Chair of the Board sold 23% of stake
- Underberg Sharon E. −$6.1M EVP, GC & Corporate Secretary sold 55% of stake
- Lane Michael −$2.7M Executive Vice President sold 49% of stake
- Kingsley Lawrence D −$1.2M Director sold 19% of stake
- JUNIUS DANIEL M −$845K Director sold 34% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-08-08 | MAZELSKY JONATHAN JAY President and CEO | Option exercise · Premium Incentive Stock Option (right-to-buy) | −183 | 0 | ||
| 2025-08-07 | Emerson Andrew EVP, CFO and Treasurer | Option exercise | +1,849 | $141.60 | $262K | 4,272.78 |
| 2025-08-07 | Emerson Andrew EVP, CFO and Treasurer | Shares withheld for taxes | −402 | $650.06 | $261K | 3,870.78 |
| 2025-08-07 | Emerson Andrew EVP, CFO and Treasurer | Option exercise · Incentive Stock Option (right-to-buy) | −1,849 | 0 | ||
| 2025-08-06 | Hunt Nimrata Executive Vice President | Option exercise | +1,218 | $141.60 | $172K | 13,573.94 |
| 2025-08-06 | Hunt Nimrata Executive Vice President | Option exercise | +5,865 | $178.26 | $1.0M | 19,438.94 |
| 2025-08-06 | Hunt Nimrata Executive Vice President | Option exercise | +5,711 | $206.94 | $1.2M | 25,149.94 |
| 2025-08-06 | Hunt Nimrata Executive Vice President | Sale | −3,018 | $629.87 | $1.9M | 22,131.94 |
| 2025-08-06 | Hunt Nimrata Executive Vice President | Sale | −2,907 | $630.91 | $1.8M | 19,224.94 |
| 2025-08-06 | Hunt Nimrata Executive Vice President | Sale | −1,218 | $630.69 | $768K | 18,006.94 |
| 2025-08-06 | Hunt Nimrata Executive Vice President | Option exercise · Non-Qualified Stock Option (right-to-buy) | −1,218 | 0 | ||
| 2025-08-06 | Hunt Nimrata Executive Vice President | Option exercise · Non-Qualified Stock Option (right-to-buy) | −5,865 | 0 | ||
| 2025-08-06 | Hunt Nimrata Executive Vice President | Option exercise · Non-Qualified Stock Option (right-to-buy) | −5,711 | 0 | ||
| 2025-08-06 | MAZELSKY JONATHAN JAY President and CEO | Option exercise | +29,260 | $67.85 | $2.0M | 112,571.3 |
| 2025-08-06 | MAZELSKY JONATHAN JAY President and CEO | Sale | −1,095 | $626.90 | $686K | 111,476.3 |
| 2025-08-06 | MAZELSKY JONATHAN JAY President and CEO | Sale | −1,525 | $628.27 | $958K | 109,951.3 |
| 2025-08-06 | MAZELSKY JONATHAN JAY President and CEO | Sale | −3,397 | $629.82 | $2.1M | 106,554.3 |
| 2025-08-06 | MAZELSKY JONATHAN JAY President and CEO | Sale | −6,056 | $630.59 | $3.8M | 100,498.3 |
| 2025-08-06 | MAZELSKY JONATHAN JAY President and CEO | Sale | −7,299 | $631.61 | $4.6M | 93,199.3 |
| 2025-08-06 | MAZELSKY JONATHAN JAY President and CEO | Sale | −3,000 | $632.56 | $1.9M | 90,199.3 |
Page 16 of 52 · 1,036 trades